Pfizer (PFE) Change in Intangibles (2013 - 2020)

Pfizer has disclosed Change in Intangibles across 8 years of filings, most recently posting $38.0 million for Q3 2020.

• In Q3 2020, Change in Intangibles fell 60.82% year-over-year to $38.0 million; the TTM figure through Sep 2020 stood at $125.0 million (down 73.35% YoY), while the FY2020 annual figure was $539.0 million, up 28.95% from the prior year.
• Change in Intangibles climbed to $38.0 million in Q3 2020, from $1.0 million in the prior quarter.
• Over the last five years, Change in Intangibles for PFE reached as high as $158.0 million in Q1 2019 and fell as low as $1.0 million in Q2 2020.
• The 5-year median for Change in Intangibles is $76.5 million (2016), against an average of $74.1 million.
• Annual changes were most pronounced in 2016 — Change in Intangibles surged 1820.0% — and 2020, when it slumped 99.08%.
• A 5-year view of Change in Intangibles shows it stood at $80.0 million in 2016, then dropped by 8.75% to $73.0 million in 2017, then soared by 43.84% to $105.0 million in 2018, then slumped by 48.57% to $54.0 million in 2019, then fell by 29.63% to $38.0 million in 2020.
• According to Business Quant data, Change in Intangibles over the past three periods registered $38.0 million, $1.0 million, and $32.0 million for Q3 2020, Q2 2020, and Q1 2020 respectively.